MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹118 Cr | ₹96 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of MOREPEN LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹118 Cr |
| Mar2025 | ₹96 Cr |
| Mar2024 | ₹39 Cr |
| Mar2023 | ₹102 Cr |
| Mar2022 | ₹97 Cr |
How is Consolidated Net Profit of MOREPEN LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹118 Cr | 22.73 | |
| Mar2025 | ₹96 Cr | 148.64 | |
| Mar2024 | ₹39 Cr | -61.97 | |
| Mar2023 | ₹102 Cr | 4.73 | |
| Mar2022 | ₹97 Cr | - | |
Compare Consolidated Net Profit of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹6,230.8 Cr | -10.1% | -4.3% | 144.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -10.1% |
-4.3% |
144.7% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses